Looking ahead, COG aims to continue its pioneering research efforts to find cures for all types of pediatric cancers. The group is focusing on personalized medicine approaches, targeting specific genetic mutations and biomarkers to develop more effective and less toxic treatments. Additionally, COG is investing in survivorship research to address the long-term health and quality of life issues faced by childhood cancer survivors.
